Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Dec;39(12):2819–2821. doi: 10.1128/aac.39.12.2819

Activities of oral antibiotics on Providencia strains isolated from institutionalized elderly patients with urinary tract infections.

G Cornaglia 1, S Frugoni 1, A Mazzariol 1, E Piacentini 1, A Berlusconi 1, R Fontana 1
PMCID: PMC163040  PMID: 8593030

Abstract

More than 250 Providencia strains isolated from the urine of institutionalized elderly patients were tested against cefaclor, cefuroxime, cefetamet, cefpodoxime, ciprofloxacin, and amoxicillin-clavulanic acid. Our results confirm the strong activities of expanded-spectrum oral cephalosporins against Providencia isolates, f1p4ell as the marked differences in susceptibilities among accurately identified Providencia species.

Full Text

The Full Text of this article is available as a PDF (161.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cornaglia G., Dainelli B., Berlutti F., Thaller M. C. Commercial identification systems often fail to identify Providencia stuartii. J Clin Microbiol. 1988 Feb;26(2):323–327. doi: 10.1128/jcm.26.2.323-327.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cornaglia G., Ligozzi M., Bauernfeind A., Satta G., Fontana R. PBP binding and periplasmic concentration as determinants of the antibacterial activities of three new oral cephalosporins in Escherichia coli. New Microbiol. 1994 Jul;17(3):203–210. [PubMed] [Google Scholar]
  3. Cullmann W., Dick W., Stieglitz M., Opferkuch W. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance. Chemotherapy. 1988;34(3):202–215. doi: 10.1159/000238572. [DOI] [PubMed] [Google Scholar]
  4. Dusi C., Mistretta M., Cornaglia G., Fontana R. Interaction with CEP-1 beta-lactamase of RU 51746-2, the active form of the new oral cephalosporin RU 51807. J Chemother. 1991 Jan;3 (Suppl 1):54–56. [PubMed] [Google Scholar]
  5. Flournoy D. J. Incidence of bacteria from clean-catch and catheterized urine of nursing home residents. J Okla State Med Assoc. 1993 Nov;86(11):550–552. [PubMed] [Google Scholar]
  6. Garibaldi R. A., Brodine S., Matsumiya S. Infections among patients in nursing homes: policies, prevalence, problems. N Engl J Med. 1981 Sep 24;305(13):731–735. doi: 10.1056/NEJM198109243051304. [DOI] [PubMed] [Google Scholar]
  7. Hawkey P. M., Pedler S. J., Turner A. Comparative in vitro activity of semisynthetic penicillins against Proteeae. Antimicrob Agents Chemother. 1983 Apr;23(4):619–621. doi: 10.1128/aac.23.4.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hawkey P. M. Providencia stuartii: a review of a multiply antibiotic-resistant bacterium. J Antimicrob Chemother. 1984 Mar;13(3):209–226. doi: 10.1093/jac/13.3.209. [DOI] [PubMed] [Google Scholar]
  9. Kitzis M. D., Liassine N., Ferré B., Gutmann L., Acar J. F., Goldstein F. In vitro activities of 15 oral beta-lactams against Klebsiella pneumoniae harboring new extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1990 Sep;34(9):1783–1786. doi: 10.1128/aac.34.9.1783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mobley H. L., Chippendale G. R., Tenney J. H., Mayrer A. R., Crisp L. J., Penner J. L., Warren J. W. MR/K hemagglutination of Providencia stuartii correlates with adherence to catheters and with persistence in catheter-associated bacteriuria. J Infect Dis. 1988 Feb;157(2):264–271. doi: 10.1093/infdis/157.2.264. [DOI] [PubMed] [Google Scholar]
  11. Mobley H. L., Chippendale G. R., Tenney J. H., Warren J. W. Adherence to uroepithelial cells of Providencia stuartii isolated from the catheterized urinary tract. J Gen Microbiol. 1986 Oct;132(10):2863–2872. doi: 10.1099/00221287-132-10-2863. [DOI] [PubMed] [Google Scholar]
  12. Nicolle L. E. Urinary tract infection in the elderly. J Antimicrob Chemother. 1994 May;33 (Suppl A):99–109. doi: 10.1093/jac/33.suppl_a.99. [DOI] [PubMed] [Google Scholar]
  13. Penner J. L., Preston M. A., Hennessy J. N., Barton L. J., Goodbody M. M. Species differences in susceptibilities of Proteeae spp. to six cephalosporins and three aminoglycosides. Antimicrob Agents Chemother. 1982 Aug;22(2):218–221. doi: 10.1128/aac.22.2.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pompei R., Cornaglia G., Ingianni A., Satta G. Use of a novel phosphatase test for simplified identification of species of the tribe Proteeae. J Clin Microbiol. 1990 Jun;28(6):1214–1218. doi: 10.1128/jcm.28.6.1214-1218.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Waites K., Rand K., Jenkins S., Yangco B., Brookings E., Gaskins D., Lewis J., Halkias K. Multicenter in vitro comparative study of fluoroquinolones after four years of widespread clinical use. Diagn Microbiol Infect Dis. 1994 Mar;18(3):181–189. doi: 10.1016/0732-8893(94)90089-2. [DOI] [PubMed] [Google Scholar]
  16. Warren J. W. Catheter-associated urinary tract infections. Infect Dis Clin North Am. 1987 Dec;1(4):823–854. [PubMed] [Google Scholar]
  17. Warren J. W. Providencia stuartii: a common cause of antibiotic-resistant bacteriuria in patients with long-term indwelling catheters. Rev Infect Dis. 1986 Jan-Feb;8(1):61–67. doi: 10.1093/clinids/8.1.61. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES